CDMO News
C Ray Secures $100M in Series A+ Financing for Radiopharmaceutical Innovations
C Ray Therapeutics (Chengdu) Co., Ltd., an enterprise specialising in radiopharmaceuticals, has completed a Series A+ financing round exceeding $100 million. The round was co-led by Shenzhen Capital Group Co., Ltd. (SCGC) and TaiLong Capital, with participation from GL Ventures,
19 November 2024